BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
24.51
+0.51 (2.13%)
Mar 3, 2025, 4:00 PM EST - Market closed
BioLife Solutions Revenue
In the year 2024, BioLife Solutions had annual revenue of $82.25M, down -42.59%. BioLife Solutions had revenue of $22.71M in the quarter ending December 31, 2024, a decrease of -30.61%.
Revenue (ttm)
$82.25M
Revenue Growth
-42.59%
P/S Ratio
13.73
Revenue / Employee
$198,681
Employees
414
Market Cap
1.14B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 82.25M | -61.02M | -42.59% |
Dec 31, 2023 | 143.27M | -18.49M | -11.43% |
Dec 31, 2022 | 161.76M | 42.60M | 35.75% |
Dec 31, 2021 | 119.16M | 71.07M | 147.79% |
Dec 31, 2020 | 48.09M | 20.72M | 75.69% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
BLFS News
- 11 days ago - BioLife Solutions to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on March 3, 2025 - PRNewsWire
- 7 weeks ago - BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue from Continuing Operations - PRNewsWire
- 2 months ago - BioLife Solutions Appoints Tony J. Hunt to its Board of Directors - PRNewsWire
- 3 months ago - BioLife Solutions Announces $6.1 million Sale of its Custom Biogenic Systems Freezer Subsidiary - PRNewsWire
- 3 months ago - BioLife Solutions, Inc. (BLFS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioLife Solutions Reports Third Quarter 2024 Financial Results - PRNewsWire
- 3 months ago - BioLife Solutions Announces $73 Million Sale of its SciSafe Biostorage Subsidiary - PRNewsWire
- 4 months ago - BioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024 - PRNewsWire